Elicio Therapeutics, Inc. (ELTX)
1.53
+0.03
(+2.00%)
USD |
NASDAQ |
Nov 20, 10:01
Elicio Therapeutics Cash from Investing (Quarterly) : 0.00 for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.00 |
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | -0.016M |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | -0.045M |
| September 30, 2024 | 0.00 |
| June 30, 2024 | -0.042M |
| March 31, 2024 | 0.003M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | -0.045M |
| June 30, 2023 | 0.03M |
| Date | Value |
|---|---|
| March 31, 2023 | -0.017M |
| December 31, 2022 | -0.095M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -0.559M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | -0.036M |
| September 30, 2021 | -0.061M |
| June 30, 2021 | -0.244M |
| March 31, 2021 | -0.041M |
| December 31, 2020 | -0.01M |
| September 30, 2020 | -0.001M |
| June 30, 2020 | -0.01M |
| March 31, 2020 | -0.02M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Lineage Cell Therapeutics, Inc. | -5.147M |
| Armata Pharmaceuticals, Inc. | -0.091M |
| Voyager Therapeutics, Inc. | 29.27M |
| Black Diamond Therapeutics, Inc. | 4.218M |
| Invivyd, Inc. | -0.585M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.36M |
| Cash from Financing (Quarterly) | 17.78M |
| Free Cash Flow | -36.99M |
| Free Cash Flow Per Share (Quarterly) | -0.3942 |
| Free Cash Flow to Equity (Quarterly) | -10.21M |
| Free Cash Flow to Firm (Quarterly) | -9.948M |
| Free Cash Flow Yield | -85.40% |